fluorodeoxyglucose f18 has been researched along with Neuroectodermal Tumors in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barwad, A; Chellapuram, S; Rastogi, S; Shamim, SA; Tripathy, S | 1 |
| Brink, I; Györke, T; Lange, A; Makó, E; Moser, E; Schäfer, O; Zajic, T | 1 |
| Baghel, NS; Nair, N; Shinto, A | 1 |
3 other study(ies) available for fluorodeoxyglucose f18 and Neuroectodermal Tumors
| Article | Year |
|---|---|
Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of Kidney With Inferior Vena Cava Thrombus: Findings on 18F-FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neuroectodermal Tumors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Vena Cava, Inferior; Venous Thrombosis | 2020 |
Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroectodermal Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity | 2006 |
Primitive neuroectodermal tumor with multiple marrow metastases at presentation.
Topics: Adolescent; Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Neuroectodermal Tumors; Positron-Emission Tomography | 2007 |